Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsing-Remitting MS”

257 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 257 results

Very early researchUnknownNCT06039007
What this trial is testing

A run-in Study on the Safety and Tolerability of a Fasting Mimicking Diet in Relapsing Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Ospedale Policlinico San Martino 24
Not applicableWithdrawnNCT01539395
What this trial is testing

A Cross-Sectional Study of MSDx Complex 1 as a Marker for Active Disease in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
MSDx, Inc.
Early research (Phase 1)UnknownNCT02903537
What this trial is testing

Tolerogenic Dendritic Cells as a Therapeutic Strategy for the Treatment of Multiple Sclerosis Patients (TOLERVIT-MS)

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Chronic Progressive
Fundació Institut Germans Trias i Pujol 16
Not applicableStudy completedNCT01909492
What this trial is testing

Measurement of Relaxin Peptide in Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Providence Health & Services 30
Post-approval studies (Phase 4)Study completedNCT01585298
What this trial is testing

STudy to vAlidate telemetRic ECG Systems for firsT Dose Administration of Fingolimod (START)

Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 6,998
Testing effectiveness (Phase 2)Active Not RecruitingNCT03846219
What this trial is testing

MRI Trial to exPlore the efficAcy and Safety of IMU-838 in Relapsing Remitting Multiple Sclerosis (EMPhASIS)

Who this might be right for
Relapsing-Remitting Multiple Sclerosis (RRMS)
Immunic AG 210
Early research (Phase 1)Study completedNCT00076934
What this trial is testing

Safety of RG2077 in Patients With Multiple Sclerosis

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
National Institute of Allergy and Infectious Diseases (NIAID) 20
Early research (Phase 1)Study completedNCT00837785
What this trial is testing

A 24-Hour Pharmacokinetic Determination of BG00012 After Single-Day Oral Administration in Subjects With MS

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Biogen 48
Not applicableStudy completedNCT01235455
What this trial is testing

Portuguese Observational Survey to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon by Using Elements of the BetaPlus Program - Nurse Support, Auto-injectors

Who this might be right for
Relapsing Remitting Multiple Sclerosis (RRMS)Secondary Progressive Multiple Sclerosis (SPMS)
Bayer 10
Testing effectiveness (Phase 2)Study completedNCT00071838
What this trial is testing

Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
National Institute of Neurological Disorders and Stroke (NINDS) 16
Not applicableStudy completedNCT00675883
What this trial is testing

COMPliance With Avonex® PS in Patients With Relapsing-Remitting MS

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Biogen 1,000
Post-approval studies (Phase 4)UnknownNCT04048577
What this trial is testing

A Pilot Study to Characterize the Biological Effect of a Pre-planned 12 Week Dose Interruption of Natalizumab

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Berkovich, Regina MD, PhD Inc. 10
Not applicableStudy completedNCT07680738
What this trial is testing

Transcranial Direct Current Stimulation for Fatigue, Mood, and Cognition in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, MSMultiple SclerosisMultiple Sclerosis (MS) - Relapsing-remitting+5 more
Universidad de Almeria 38
Post-approval studies (Phase 4)UnknownNCT05340985
What this trial is testing

Investigating the Effects of Hydroxyvitamin D3 on Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingAdult ALLVitamin D3 Deficiency
Tehran University of Medical Sciences 54
Not applicableStudy completedNCT00818038
What this trial is testing

A Proof of Concept Study to Evaluate the Effectiveness of Tysabri in Relapsing Remitting Multiple Sclerosis (RRMS) Patient Bladder Function

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Biogen 30
Post-approval studies (Phase 4)Ended earlyNCT00780455
What this trial is testing

Rehabilitation Study in MS Patients

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Bayer 4
Not applicableStudy completedNCT01541618
What this trial is testing

MSDx Complex 1 as a Marker for Therapy Response in Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
MSDx, Inc. 15
Not applicableStudy completedNCT01142518
What this trial is testing

An Observational Study of Multiple Sclerosis (MS) Patients Starting or Restarting Baseline Treatment With Interferon Beta 1a After the Use of Escalation Treatment With Mitoxantrone

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Merck KGaA, Darmstadt, Germany 86
Post-approval studies (Phase 4)WithdrawnNCT02675413
What this trial is testing

Mechanisms of Action of Dimethyl Fumarate (Tecfidera) in Relapsing MS

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Washington University School of Medicine
Large-scale testing (Phase 3)Active Not RecruitingNCT05123703
What this trial is testing

Evaluate Safety and Efficacy of Ocrelizumab in Comparison With Fingolimod in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Hoffmann-La Roche 188
Next Page